Bought Teva in March 2020. The assumption was that Teva had been beaten down way more than it should have. The stock rebounded quickly and has been pretty much flat ever since.
Looking 3-5 years ahead, I don't see any prospects that would make me think this will be a market beater, so I'm taking profits and will be investing in a higher growth potential stock soon.
Post a Comment